
On March 2, 1999, Hewlett-Packard announced a plan to create a separate company, subsequently named Agilent Technologies, Inc., that comprised Hewlett-Packard's test and measurement, semiconductor products, healthcare solutions and chemical analysis businesses, related portions of Hewlett-Packard Laboratories, and associated infrastructure. After the completion of our initial public offering on November 23, 1999, Hewlett-Packard owns approximately 84.1% of the outstanding common stock. Hewlett-Packard has also announced its intention to distribute to its stockholders all of its remaining interest in Aligent by the middle of calendar year 2000.
Agilent is a global diversified technology company that provides enabling solutions to high growth markets within the communications, electronics, healthcare and life sciences industries. Its broad technology portfolio and experience in working with market-leading customers in more than 120 countries have allowed it to establish and advance leadership across multiple markets. Its four primary businesses include:
These test and measurement and semiconductor businesses share focus on growth opportunities in the communications sector, while the healthcare and chemical analysis businesses share focus on growth opportunities in healthcare and life sciences. All of these businesses are supported by the technical expertise of Agilent Technologies Laboratories, one of the world's foremost industrial research and development organizations. Agilent Technologies Laboratories is thoroughly integrated with these businesses in design, development and manufacturing engineering, and substantially all of its development engineers are aligned with the research and development teams in the individual businesses.
Aligent products are sold primarily through a direct sales force, but it also utilizes distributors, resellers, telesales and electronic commerce. Of its total net revenue of $8.3 billion in the fiscal year ended October 31, 1999, 44.8% was generated in the United States and 55.2% internationally. As of Aligent employed approximately 42,000 people worldwide. It has major research and development and manufacturing sites in California, Colorado, Delaware, Massachusetts, and Washington in the United States and in China, Germany, Japan, Korea, Malaysia, Singapore and the United Kingdom.